CA Stock MarketDetailed Quotes

CRDL Cardiol Therapeutics Inc

Watchlist
  • 2.720
  • -0.080-2.86%
15min DelayTrading Aug 16 10:31 ET
190.08MMarket Cap-6181P/E (TTM)

Cardiol Therapeutics Inc Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
10.81%-4.78M
30.40%-6.92M
7.49%-25.18M
48.47%-6.46M
-101.63%-3.41M
-108.62%-5.35M
4.49%-9.95M
-15.64%-27.22M
-213.93%-12.55M
73.48%-1.69M
Net income from continuing operations
11.79%-6.59M
-29.49%-9.18M
9.06%-28.13M
-1.62%-7.64M
25.61%-5.93M
-15.14%-7.47M
20.83%-7.09M
2.24%-30.93M
-20.10%-7.52M
19.56%-7.97M
Operating gains losses
-8,212.79%-840.73K
1,814.59%1.32M
87.91%-943.76K
78.36%-1.45M
-61.16%575.32K
-98.90%10.36K
97.82%-76.84K
-61.88%-7.81M
---6.71M
--1.48M
Depreciation and amortization
5.83%61.91K
5.87%61.62K
12.94%248.36K
15.04%66.76K
19.12%64.89K
8.77%58.5K
8.55%58.21K
-0.23%219.91K
4.40%58.03K
-2.01%54.48K
Remuneration paid in stock
170.95%1.81M
111.35%902.1K
-17.08%4.16M
6.83%1.01M
-42.73%2.05M
214.46%666.4K
-59.98%426.82K
-41.01%5.01M
-79.34%947.96K
280.52%3.58M
Other non cashItems
362.65%6.37K
-63.28%6.64K
-93.94%32.38K
100.55%6.98K
-97.28%5.94K
-99.81%1.38K
-97.91%18.08K
-87.05%534.43K
-220.09%-1.26M
-88.93%218.62K
Change In working capital
-43.36%782.04K
99.06%-31.03K
-109.50%-545.88K
-20.63%1.54M
-119.22%-181.28K
-50.57%1.38M
-4,564.67%-3.28M
7,411.68%5.75M
39.71%1.94M
70.76%943.01K
-Change in receivables
-27.56%74.68K
-151.69%-37.23K
374.15%200.33K
134.57%9.72K
131.94%15.47K
25.15%103.09K
191.33%72.03K
60.97%-73.07K
-29.27%-28.12K
-116.21%-48.45K
-Change in inventory
----
----
--0
----
----
----
----
--0
----
----
-Change in prepaid assets
-84.50%129.09K
-8.14%-805.5K
-59.41%546.47K
137.56%678.38K
-122.24%-219.77K
29.43%832.72K
-30.52%-744.86K
162.70%1.35M
130.65%285.56K
62.05%988.05K
-Change in payables and accrued expense
29.97%578.26K
131.09%811.71K
-128.89%-1.29M
-49.42%850.28K
575.52%23.02K
-78.48%444.93K
-461.06%-2.61M
86.99%4.47M
-28.19%1.68M
100.96%3.41K
Cash from discontinued investing activities
Operating cash flow
10.81%-4.78M
30.40%-6.92M
7.49%-25.18M
48.47%-6.46M
-101.63%-3.41M
-108.62%-5.35M
4.49%-9.95M
-15.64%-27.22M
-213.93%-12.55M
73.48%-1.69M
Investing cash flow
Cash flow from continuing investing activities
2.34%-3.8K
92.16%-3.46K
13.92%-64.31K
77.62%-10.71K
39.95%-5.58K
-82.85%-3.89K
-185.44%-44.14K
-478.42%-74.71K
-47.83K
28.09%-9.29K
Net PPE purchase and sale
2.34%-3.8K
92.16%-3.46K
13.92%-64.31K
77.62%-10.71K
39.95%-5.58K
-82.85%-3.89K
-185.44%-44.14K
-478.42%-74.71K
---47.83K
28.09%-9.29K
Cash from discontinued investing activities
Investing cash flow
2.34%-3.8K
92.16%-3.46K
13.92%-64.31K
77.62%-10.71K
39.95%-5.58K
-82.85%-3.89K
-185.44%-44.14K
-478.42%-74.71K
---47.83K
28.09%-9.29K
Financing cash flow
Cash flow from continuing financing activities
664.03%78.08K
651.52%76.35K
-2.67%-55.38K
0.00%-13.84K
0.00%-13.84K
-4.35%-13.84K
-6.66%-13.84K
-100.06%-53.93K
-100.02%-13.84K
-100.59%-13.84K
Net issuance payments of debt
33.34%-9.23K
0.00%-13.84K
-2.67%-55.38K
0.00%-13.84K
0.00%-13.84K
-4.35%-13.84K
-6.66%-13.84K
-3.89%-53.93K
-6.66%-13.84K
-6.66%-13.84K
Net common stock issuance
----
----
--0
----
----
----
----
--0
----
----
Proceeds from stock option exercised by employees
--87.31K
--90.2K
--0
----
----
--0
--0
--0
----
----
Cash from discontinued financing activities
Financing cash flow
664.03%78.08K
651.52%76.35K
-2.67%-55.38K
0.00%-13.84K
0.00%-13.84K
-4.35%-13.84K
-6.66%-13.84K
-100.06%-53.93K
-100.02%-13.84K
-100.59%-13.84K
Net cash flow
Beginning cash position
-42.24%28.57M
-41.26%34.93M
-29.12%59.47M
-38.14%40.54M
-36.21%44.94M
-33.91%49.47M
-29.12%59.47M
498.20%83.9M
128.72%65.53M
115.33%70.45M
Current changes in cash
12.48%-4.7M
31.53%-6.85M
7.49%-25.3M
48.53%-6.49M
-100.05%-3.43M
-108.06%-5.37M
4.20%-10M
-139.13%-27.35M
-122.82%-12.61M
57.79%-1.72M
Effect of exchange rate changes
-82.32%149.68K
17,693.37%491.1K
-73.90%762.04K
-86.54%880.95K
69.79%-968.2K
146.82%846.53K
-99.80%2.76K
26,335.83%2.92M
--6.54M
---3.2M
End cash Position
-46.55%24.02M
-42.24%28.57M
-41.26%34.93M
-41.26%34.93M
-38.14%40.54M
-36.21%44.94M
-33.91%49.47M
-29.12%59.47M
-29.12%59.47M
128.72%65.53M
Free cash from
10.80%-4.78M
30.67%-6.93M
7.51%-25.24M
48.58%-6.48M
-100.86%-3.42M
-108.59%-5.36M
4.21%-9.99M
-15.89%-27.3M
-215.13%-12.59M
73.39%-1.7M
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 10.81%-4.78M30.40%-6.92M7.49%-25.18M48.47%-6.46M-101.63%-3.41M-108.62%-5.35M4.49%-9.95M-15.64%-27.22M-213.93%-12.55M73.48%-1.69M
Net income from continuing operations 11.79%-6.59M-29.49%-9.18M9.06%-28.13M-1.62%-7.64M25.61%-5.93M-15.14%-7.47M20.83%-7.09M2.24%-30.93M-20.10%-7.52M19.56%-7.97M
Operating gains losses -8,212.79%-840.73K1,814.59%1.32M87.91%-943.76K78.36%-1.45M-61.16%575.32K-98.90%10.36K97.82%-76.84K-61.88%-7.81M---6.71M--1.48M
Depreciation and amortization 5.83%61.91K5.87%61.62K12.94%248.36K15.04%66.76K19.12%64.89K8.77%58.5K8.55%58.21K-0.23%219.91K4.40%58.03K-2.01%54.48K
Remuneration paid in stock 170.95%1.81M111.35%902.1K-17.08%4.16M6.83%1.01M-42.73%2.05M214.46%666.4K-59.98%426.82K-41.01%5.01M-79.34%947.96K280.52%3.58M
Other non cashItems 362.65%6.37K-63.28%6.64K-93.94%32.38K100.55%6.98K-97.28%5.94K-99.81%1.38K-97.91%18.08K-87.05%534.43K-220.09%-1.26M-88.93%218.62K
Change In working capital -43.36%782.04K99.06%-31.03K-109.50%-545.88K-20.63%1.54M-119.22%-181.28K-50.57%1.38M-4,564.67%-3.28M7,411.68%5.75M39.71%1.94M70.76%943.01K
-Change in receivables -27.56%74.68K-151.69%-37.23K374.15%200.33K134.57%9.72K131.94%15.47K25.15%103.09K191.33%72.03K60.97%-73.07K-29.27%-28.12K-116.21%-48.45K
-Change in inventory ----------0------------------0--------
-Change in prepaid assets -84.50%129.09K-8.14%-805.5K-59.41%546.47K137.56%678.38K-122.24%-219.77K29.43%832.72K-30.52%-744.86K162.70%1.35M130.65%285.56K62.05%988.05K
-Change in payables and accrued expense 29.97%578.26K131.09%811.71K-128.89%-1.29M-49.42%850.28K575.52%23.02K-78.48%444.93K-461.06%-2.61M86.99%4.47M-28.19%1.68M100.96%3.41K
Cash from discontinued investing activities
Operating cash flow 10.81%-4.78M30.40%-6.92M7.49%-25.18M48.47%-6.46M-101.63%-3.41M-108.62%-5.35M4.49%-9.95M-15.64%-27.22M-213.93%-12.55M73.48%-1.69M
Investing cash flow
Cash flow from continuing investing activities 2.34%-3.8K92.16%-3.46K13.92%-64.31K77.62%-10.71K39.95%-5.58K-82.85%-3.89K-185.44%-44.14K-478.42%-74.71K-47.83K28.09%-9.29K
Net PPE purchase and sale 2.34%-3.8K92.16%-3.46K13.92%-64.31K77.62%-10.71K39.95%-5.58K-82.85%-3.89K-185.44%-44.14K-478.42%-74.71K---47.83K28.09%-9.29K
Cash from discontinued investing activities
Investing cash flow 2.34%-3.8K92.16%-3.46K13.92%-64.31K77.62%-10.71K39.95%-5.58K-82.85%-3.89K-185.44%-44.14K-478.42%-74.71K---47.83K28.09%-9.29K
Financing cash flow
Cash flow from continuing financing activities 664.03%78.08K651.52%76.35K-2.67%-55.38K0.00%-13.84K0.00%-13.84K-4.35%-13.84K-6.66%-13.84K-100.06%-53.93K-100.02%-13.84K-100.59%-13.84K
Net issuance payments of debt 33.34%-9.23K0.00%-13.84K-2.67%-55.38K0.00%-13.84K0.00%-13.84K-4.35%-13.84K-6.66%-13.84K-3.89%-53.93K-6.66%-13.84K-6.66%-13.84K
Net common stock issuance ----------0------------------0--------
Proceeds from stock option exercised by employees --87.31K--90.2K--0----------0--0--0--------
Cash from discontinued financing activities
Financing cash flow 664.03%78.08K651.52%76.35K-2.67%-55.38K0.00%-13.84K0.00%-13.84K-4.35%-13.84K-6.66%-13.84K-100.06%-53.93K-100.02%-13.84K-100.59%-13.84K
Net cash flow
Beginning cash position -42.24%28.57M-41.26%34.93M-29.12%59.47M-38.14%40.54M-36.21%44.94M-33.91%49.47M-29.12%59.47M498.20%83.9M128.72%65.53M115.33%70.45M
Current changes in cash 12.48%-4.7M31.53%-6.85M7.49%-25.3M48.53%-6.49M-100.05%-3.43M-108.06%-5.37M4.20%-10M-139.13%-27.35M-122.82%-12.61M57.79%-1.72M
Effect of exchange rate changes -82.32%149.68K17,693.37%491.1K-73.90%762.04K-86.54%880.95K69.79%-968.2K146.82%846.53K-99.80%2.76K26,335.83%2.92M--6.54M---3.2M
End cash Position -46.55%24.02M-42.24%28.57M-41.26%34.93M-41.26%34.93M-38.14%40.54M-36.21%44.94M-33.91%49.47M-29.12%59.47M-29.12%59.47M128.72%65.53M
Free cash from 10.80%-4.78M30.67%-6.93M7.51%-25.24M48.58%-6.48M-100.86%-3.42M-108.59%-5.36M4.21%-9.99M-15.89%-27.3M-215.13%-12.59M73.39%-1.7M
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion--------Unqualified Opinion----

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Heat List
CA
Overall
Symbol
Latest Price
% Chg